A New Treatment Option for Parkinson’s A new treatment option for Parkinson’s disease (PD) just received approval. The US Food and Drug Administration (FDA) has approved JUVMO (tavapadon) for PD ...

When most people hear the phrase “Medicare payment policy,” their eyes glaze over. It sounds technical, bureaucratic, and far removed from daily life. But for people living with Parkinson’s disease ...

Parkinson’s disease (PD) medications continue to expand, which is giving patients more options than ever before. However, choosing between different formulations, delivery systems, and add-on ...

NEW YORK, NY, AUGUST 24, 2026 – The American Parkinson Disease Association (APDA) today announced the launch of a new Spanish-language microsite, expanding access to critical information and resources ...

The World Parkinson Congress (WPC) is an international conference that takes place every three years and brings together researchers, clinicians, people with Parkinson’s disease (PD), care partners, ...

Together, we can make a powerful difference in the lives of people living with Parkinson’s. Let’s walk with purpose. Let’s walk with optimism. Let’s walk together.

A major milestone has been reached as Japan has approved the world’s first stem-cell-based therapy for Parkinson’s disease (PD). The innovation was developed by Sumitomo Pharma in collaboration with ...

Parkinson’s disease (PD) progresses in stages, each presenting unique challenges and opportunities for care. When discussing Parkinson’s disease, many people reference the Hoehn and Yahr scale to ...

La APDA es una red nacional de base comunitaria dedicada a combatir la enfermedad de Parkinson (EP). La APDA trabaja incansablemente para apoyar a cerca de un millón de personas diagnosticadas con la ...

This study investigated whether air pollution affects LBD risk by analyzing health records between 2000 and 2014 from 56.5 million US adults over the age of 65. Based on zip code, the study ...

This section will help you understand the basics of Parkinson’s disease, how it affects the brain, its symptoms and ongoing research.

The American Parkinson Disease Association (APDA) proudly announces $4.04 million in new funding for cutting-edge Parkinson’s disease (PD) research – representing a 55% increase in research funding ...